default author photo

Yang Cao

Huazhong University of Science and Technology - Department of Hematology

China

SCHOLARLY PAPERS

2

DOWNLOADS

148

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma with Extramedullary Disease and Plasma Cell Leukemia

Number of pages: 44 Posted: 17 Dec 2019
Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Wuhan No. 1 Hospital, Huazhong University of Science and Technology - Department of Hematology, Wuhan University of Science and Technology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Wuhan University of Science and Technology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Wuhan University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology and Huazhong University of Science and Technology - Department of Hematology
Downloads 93 (730,864)
Citation 2

Abstract:

Loading...

Anti-BCMA CAR T-Cell; Relapsed or Refractory; Multiple Myeloma; Extramedullary disease

2.

The Liv-1-Grpel1 Axis Dictates Cell Fate During Anti-Mitotic Agent-Damaged Mitosis

, EBioMedicine, Volume 49, November 2019, Pages 26-39, https://doi.org/10.1016/j.ebiom.2019.09.054
Number of pages: 60 Posted: 22 Jul 2019
Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Tongji Medical College, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Department of Gastrointestinal Surgery, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center and Huazhong University of Science and Technology - Department of Obstetrics and Gynecology
Downloads 55 (1,020,567)

Abstract:

Loading...

LIV-1-GRPEL1 axis; mitotic exit; Apoptosis; anti-mitotic agents; human cancer